As per this study, the Global Biopharmaceutical Excipients Market was valued USD XX MN (by revenue) in 2019 and is anticipated to reach USD XX MN by 2026 with a CAGR of XX%.
Excipients are the ingredients used for the formulation of dosage. The excipients along with active pharmaceutical ingredients make up the dosage form. Biopharmaceutical excipients act as bulking agents and can also be used to improve the bioavailability of drugs in some instances. These excipients must suit the intended dosage form and comply with the standard requirement. Also, their compatibility must be scrutinized in a dosage form that involves taste, coating, oil base and other aspects.
The growing demand for biopharmaceutical products coupled with an increasing geriatric population is boosting the biopharmaceutical excipients market growth. Additionally, advancements in functional biopharmaceutical excipients and the rapidly expanding biopharmaceutical sector are further pushing the market growth. On the other hand, cost and time-intensive drug development process and the quality concerns of excipients manufacturers is projected to restrain the market growth.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of biopharmaceutical excipients.
The broad biopharmaceutical excipients market has been sub-grouped into chemistry, functionality, and application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
- Synthetic Sources
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for biopharmaceutical excipients in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Global Biopharmaceutical Excipients Market Share by Region (Representative Graph)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the biopharmaceutical excipients market include Ashland Inc., BASF SE, Croda International Plc, Evonik Industries AG, FMC Corporation, Innophos Holdings Inc., MEGGLE Group Wasserburg BG Excipients & Technology, Roquette Group, The Dow Chemical Company, and The Lubrizol Corporation. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.